These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16621431)

  • 41. Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma.
    Chua TC; Yan TD; Deraco M; Glehen O; Moran BJ; Sugarbaker PH;
    Br J Surg; 2011 Jan; 98(1):60-4. PubMed ID: 20872843
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trials.
    Kluger MD; Taub RN; Hesdorffer M; Jin Z; Chabot JA
    Eur J Surg Oncol; 2010 Oct; 36(10):997-1003. PubMed ID: 20674253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
    Iversen LH; Rasmussen PC; Laurberg S
    Ugeskr Laeger; 2007 Sep; 169(38):3179-81. PubMed ID: 17910824
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin.
    de Bree E; van Ruth S; Schotborgh CE; Baas P; Zoetmulder FA
    Ann Surg Oncol; 2007 Oct; 14(10):3019-26. PubMed ID: 17638057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with pseudomyxoma peritonei.
    Deraco M; De Simone M; Rossi CR; Cavaliere F; Di Filippo F; Vaira M; Piatti P; Kusamura S
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):35-9. PubMed ID: 16767904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Peritoneal mesothelioma: results of a complicated and aggressive procedure incorporating peritonectomy and intraperitoneal hyperthermic chemotherapy, and prospects derived from bench-to-bedside research].
    Deraco M; Kusamura S; Baratti D; Casali P; Zaffaroni N
    Tumori; 2003; 89(4 Suppl):56-7. PubMed ID: 12903546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spontaneous pregnancy following cytoreduction with peritonectomy and hyperthermic intraperitoneal chemotherapy.
    Kyser K; Bidus MA; Rodriguez M; Rose GS; Elkas JC
    Gynecol Oncol; 2006 Jan; 100(1):198-200. PubMed ID: 16194563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution.
    Sugarbaker PH
    J Surg Oncol; 2005 Nov; 92(2):142-6. PubMed ID: 16231365
    [No Abstract]   [Full Text] [Related]  

  • 49. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
    Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
    Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating CA125 and diffuse malignant peritoneal mesothelioma.
    Baratti D; Kusamura S; Deraco M
    Eur J Surg Oncol; 2009 Nov; 35(11):1198-9. PubMed ID: 19423265
    [No Abstract]   [Full Text] [Related]  

  • 52. Cytoreductive surgery followed by intra peritoneal hyperthermic perfusion in the treatment of peritoneal surface malignancies: morbidity and mortality with closed abdomen technique.
    Kusamura S; Deraco M; Baratti D; Inglese MG; Costanzo P; Favaro M; Manzi R; Gavazzi C
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):207-12. PubMed ID: 16767933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan.
    Raspagliesi F; Kusamura S; Campos Torres JC; de Souza GA; Ditto A; Zanaboni F; Younan R; Baratti D; Mariani L; Laterza B; Deraco M
    Eur J Surg Oncol; 2006 Aug; 32(6):671-5. PubMed ID: 16621425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term survival of a patient with primary papillary serous carcinoma of the peritoneum treated by subtotal peritonectomy plus intraoperative chemohyperthermia.
    Ajisaka H; Yonemura Y; Bando E; Fushida S; Nishimura G; Miwa K
    Hepatogastroenterology; 2002; 49(46):1027-9. PubMed ID: 12143193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy.
    Hadi R; Saunders V; Utkina O; Clingan P; Kam P; Links M; Morris DL
    ANZ J Surg; 2006 Mar; 76(3):156-61. PubMed ID: 16626358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome.
    Brouquet A; Goéré D; Lefèvre JH; Bonnet S; Dumont F; Raynard B; Elias D
    Ann Surg Oncol; 2009 Oct; 16(10):2744-51. PubMed ID: 19626375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of explorative laparoscopy to evaluate optimal candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal mesothelioma.
    Laterza B; Kusamura S; Baratti D; Oliva GD; Deraco M
    In Vivo; 2009; 23(1):187-90. PubMed ID: 19368148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors and clinicopathological study of prognostic factors in the peritoneal mesothelioma.
    Tudor EC; Chua TC; Liauw W; Morris DL
    Am Surg; 2010 Apr; 76(4):400-5. PubMed ID: 20420251
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of peritoneal mesothelioma using cytoreduction and intraperitoneal hyperthermic chemotherapy].
    Costamagna D; Scuderi S; Vaira M; Barone R; De Simone M
    Tumori; 2003; 89(4 Suppl):40-2. PubMed ID: 12903541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites.
    Garofalo A; Valle M; Garcia J; Sugarbaker PH
    Eur J Surg Oncol; 2006 Aug; 32(6):682-5. PubMed ID: 16631341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.